Thymocyte Drug Target of Immune Reconstitution
Small Business Information
ORPHAGEN PHARMACEUTICALS, 5310 EASTGATE MALL, SAN DIEGO, CA, 92121
AbstractDESCRIPTION (provided by applicant): The long-term objective of this proposal is to develop the first class of small molecule, orally-bioavailable drugs that increases T cell production from the thymus and enhances immune reconstitution in AIDS and other
* information listed above is at the time of submission.